Imfinzi has received priority review by the FDA for the treatment of lung cancer
AstraZeneca on Thursday the US Food and Drug Administration (FDA) said its top-selling cancer drug Imfinzi has received priority review for patients with limited-stage small-cell lung cancer in the United States.
ПОПУЛЯРНЫЕ ПОСТЫ
Poland prepares for peaking floods
Сентябрь 20, 2024
Italy evacuates thousands as Boris hits the north
Сентябрь 20, 2024
China and the US race to tame nuclear fusion for clean energy
Сентябрь 20, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ